{"id":3671,"date":"2025-03-31T18:11:47","date_gmt":"2025-03-31T18:11:47","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/alfentanil-txt\/"},"modified":"2025-03-31T18:11:47","modified_gmt":"2025-03-31T18:11:47","slug":"alfentanil-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/alfentanil-txt\/","title":{"rendered":"Alfentanil.txt"},"content":{"rendered":"<h1>Alfentanil<\/h1>\n<p><H3>  CLINICAL USE <\/H3><br \/>\nOpioid analgesic:<\/p>\n<li>Short surgical procedures\n<li>Intensive care sedation\n<p><H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3><\/p>\n<li>IV injection:\n<p>Spontaneous respiration: up to <\/p>\n<p>\u2014<br \/>\n500 micrograms over 30 seconds;<br \/>\nsupplemental dose: 250 micrograms<br \/>\nassisted ventilation: 30\u201350 <\/p>\n<p>\u2014<br \/>\nmicrograms\/kg; supplemental dose:<br \/>\n15 micrograms\/kg<\/p>\n<li>By IV infusion  with assisted ventilation:\n<p>loading dose 50\u2013100 micrograms\/kg as<br \/>\nbolus or fast infusion over 10 minutes,<br \/>\nfollowed by 0.5\u20131 micrograms\/kg\/minute.<br \/>\nDiscontinue infusion 30 minutes before<br \/>\nanticipated end of surgery<\/p>\n<li>For analgesia and suppression of\n<p>respiratory activity during intensive care<br \/>\nwith assisted ventilation: by  IV infusion<br \/>\n2 mg\/hour, adjusted according to response<br \/>\n(usual range 0.5\u201310 mg\/hour)<\/p>\n<li>For more rapid initial control give 5 mg\n<p>IV in divided portions over 10 minutes<br \/>\n(slower if hypotension or bradycardia<br \/>\ndevelops); additional doses of 0.5\u20131 mg<br \/>\nmay be given by IV injection during short<br \/>\npainful procedures<br \/>\n<H3>  PHARMACOKINETICS    <\/H3><br \/>\n<LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n453 (as hydrochloride)\n<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n92\n<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp :<br \/>\n0.4\n<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n0.4\u20131\n<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n1\u20132 (average<br \/>\n90 minutes)\/<br \/>\nUnchanged<br \/>\n<H3>  DOSE IN RENAL IMPAIRMENT <\/H3><br \/>\n<H4>GFR (mL\/MIN)<\/H4><br \/>\n<LI> 20 to 50  &amp;nbsp &amp;nbsp : Dose as in normal renal function<br \/>\n<LI> 10 to 20  &amp;nbsp &amp;nbsp : Dose as in normal renal function<br \/>\n<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\nDose as in normal renal function<br \/>\n<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><br \/>\n<LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:<br \/>\nNot dialysed. Dose as in normal renal function <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\nNot dialysed. Dose as in normal renal function<br \/>\n<LI>HDF\/high flux  &amp;nbsp :<br \/>\nUnknown dialysability. Dose as in<br \/>\nnormal renal function<br \/>\n<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:<br \/>\nNot dialysed. Dose as in normal renal function<br \/>\n<H3> IMPORTANT DRUG INTERACTIONS  <\/H3><br \/>\nPotentially hazardous interactions with other drugs<\/p>\n<li>Antidepressants: possible CNS excitation\n<p>or depression (hypertension or<br \/>\nhypotension) in patients also receiving<br \/>\nMAOIs (including moclobemide) \u2013 avoid<br \/>\nconcomitant use; possibly increased<br \/>\nsedative effects with tricyclics<\/p>\n<li>Antifungals: metabolism inhibited by\n<p>fluconazole and ketoconazole (risk<br \/>\nof prolonged or delayed respiratory<br \/>\ndepression); metabolism possibly inhibited<br \/>\nby itraconazole<\/p>\n<li>Antivirals: concentration possibly\n<p>increased by ritonavir<\/p>\n<li>Sodium oxybate: enhanced effect of\n<p>sodium oxybate \u2013 avoid concomitant use<br \/>\n<H3> ADMINISTRATION  <\/H3><br \/>\n<H4> Reconstition<\/H4><br \/>\n\u2013<br \/>\n<H4>  Route  <\/H4><br \/>\nIV bolus, <H4> IV infusion  <\/H4><\/p>\n<p><H4>  Rate of Administration  <\/H4><br \/>\nSee dose<\/p>\n<p><H4>Comments<\/H4><\/p>\n<li>Alfentanil can be mixed with sodium\n<p>chloride 0.9%, glucose 5%, or compound<br \/>\nsodium lactate injection (Hartmann\u2019s<br \/>\nsolution) at a concentration of 0.5 mg\/<br \/>\nmL, but can be used at 2 mg\/mL or even<br \/>\nundiluted at 5 mg\/mL. <\/p>\n<p><H4>  OTHER INFORMATION  <\/H4><\/p>\n<li>Free fraction of drug is increased in renal\n<p>failure, hence dose requirements may be<br \/>\nreduced<\/p>\n<li>IV administration: 500 micrograms\n<p>alfentanil has peak effect in 90 seconds,<br \/>\nand provides analgesia for 5\u201310 minutes<br \/>\n(in unpremedicated adults)<\/p>\n<li>Transient fall in BP and bradycardia may\n<p>occur on administration<\/p>\n<li>Analgesic potency = \u00bc that of fentanyl\n<p>Duration of action = \u2153 that of an equi-<\/p>\n<p>analgesic dose of fentanyl<\/p>\n<li>Onset of action = 4 times more rapid than\n<p>an equi-analgesic dose of fentanyl<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alfentanil CLINICAL USE Opioid analgesic: Short surgical procedures Intensive care<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-3671","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=3671"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3671\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=3671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=3671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=3671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}